New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.

FDA Clears Brain Modulation Device for PTSD

The non-invasive device teaches patients how to regulate activity in the zone of the brain associated with emotion.

1 L4 A1713 E1679613493781
GrayMatters Health

According to a recent article from The Times of Israel, the FDA has approved a brain stimulation device that treats PTSD. The device is called BrainsWay Deep TMS, and it was developed by Israeli company BrainsWay. It uses transcranial magnetic stimulation to stimulate specific areas of the brain associated with PTSD. 

The device is non-invasive and is intended to be used in combination with traditional forms of PTSD treatment, such as therapy and medication. Clinical trials showed that the device can significantly reduce symptoms of PTSD, including anxiety, depression, and insomnia. The FDA's approval is considered a major breakthrough in the treatment of PTSD, which affects millions of people worldwide.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts